Lista de obras - Teh-Ia Huo - Dominio Público Uruguay

A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria

artículo científico publicado en 2019

A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma

artículo científico publicado en 2019

Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

artículo científico publicado en 2020

Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma

scientific article published on 20 September 2019

Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?

artículo científico publicado en 2019

Changing faces of hepatocellular carcinoma: East vs West

artículo científico publicado en 2020

Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.

artículo científico publicado en 2018

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score

scientific article published in PLoS ONE

Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma

artículo científico publicado en 2018

Development of a Graphene Oxide-Incorporated Polydimethylsiloxane Membrane with Hexagonal Micropillars

article

Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants

scientific article published on 18 January 2020

Evolution of hepatocellular carcinoma: non-B, non-C and beyond

artículo científico publicado en 2019

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.

artículo científico publicado en 2017

Is CT-enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma?

artículo científico publicado en 2020

Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation

scientific article published on 06 February 2020

Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?

artículo científico publicado en 2018

Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system.

artículo científico publicado en 2018

Metavir Fibrosis Stage in Hepatitis C-Related Hepatocellular Carcinoma and Association with Noninvasive Liver Reserve Models

artículo científico publicado en 2020

Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls?

artículo científico publicado en 2020

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

artículo científico publicado en 2018

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

artículo científico publicado en 2017

Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C

scientific article published on 07 February 2019

Staging and restaging for hepatocellular carcinoma: Solution of confusion?

artículo científico publicado en 2019

Thrombocytosis is Associated with Worse Survival in Patients with Hepatocellular Carcinoma

artículo científico publicado en 2020

Treating small hepatocellular carcinoma: Stereotactic body radiation therapy vs RFA

artículo científico publicado en 2020

Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker?

scientific article published on 21 September 2020

Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations

artículo científico publicado en 2020

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.

artículo científico publicado en 2018

Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma.

artículo científico publicado en 2017

Lista de obras de Teh-Ia Huo

A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria

A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma

Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma

Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?

Changing faces of hepatocellular carcinoma: East vs West

Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score

Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma

Development of a Graphene Oxide-Incorporated Polydimethylsiloxane Membrane with Hexagonal Micropillars

Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants

Evolution of hepatocellular carcinoma: non-B, non-C and beyond

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.

Is CT-enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma?

Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation

Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?

Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system.

Metavir Fibrosis Stage in Hepatitis C-Related Hepatocellular Carcinoma and Association with Noninvasive Liver Reserve Models

Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls?

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C

Staging and restaging for hepatocellular carcinoma: Solution of confusion?

Thrombocytosis is Associated with Worse Survival in Patients with Hepatocellular Carcinoma

Treating small hepatocellular carcinoma: Stereotactic body radiation therapy vs RFA

Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker?

Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.

Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma.